These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1459256)

  • 1. Effect of human corticotropin-releasing hormone on gonadotropin secretion in cycling and postmenopausal women.
    Fischer UG; Wood SH; Bruhn J; Roseff SJ; Mortola J; Rivier JE; Yen SS
    Fertil Steril; 1992 Dec; 58(6):1108-12. PubMed ID: 1459256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response effects of exogenous pulsatile human corticotropin-releasing hormone on adrenocorticotropin, cortisol, and gonadotropin concentrations in agonadal women.
    Thomas MA; Rebar RW; LaBarbera AR; Pennington EJ; Liu JH
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1249-54. PubMed ID: 1851183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.
    Barbarino A; De Marinis L; Tofani A; Della Casa S; D'Amico C; Mancini A; Corsello SM; Sciuto R; Barini A
    J Clin Endocrinol Metab; 1989 Mar; 68(3):523-8. PubMed ID: 2493035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous opioid peptides modulate the effect of corticotropin-releasing factor on gonadotropin release in the primate.
    Gindoff PR; Ferin M
    Endocrinology; 1987 Sep; 121(3):837-42. PubMed ID: 3113919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibitory action of corticotropin-releasing hormone on gonadotropin secretion in the ovariectomized rhesus monkey is not mediated by adrenocorticotropic hormone.
    Xiao EN; Ferin M
    Biol Reprod; 1988 May; 38(4):763-7. PubMed ID: 2840981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticotropin-releasing hormone inhibits gonadotropin secretion in the ovariectomized rhesus monkey.
    Olster DH; Ferin M
    J Clin Endocrinol Metab; 1987 Aug; 65(2):262-7. PubMed ID: 3110201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone treatment prevents the inhibitory effect of corticotropin-releasing hormone on gonadotropin release in the primate.
    Gindoff PR; Xiao EN; Luckhaus J; Ferin M
    Neuroendocrinology; 1989 Feb; 49(2):202-6. PubMed ID: 2498756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute inhibition of gonadotropin secretion by corticotropin-releasing hormone in the primate: are the adrenal glands involved?
    Xiao E; Luckhaus J; Niemann W; Ferin M
    Endocrinology; 1989 Apr; 124(4):1632-7. PubMed ID: 2494035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-melanocyte-stimulating hormone antagonizes the inhibitory effect of corticotropin-releasing hormone on luteinizing hormone secretion during the luteal phase in normal women.
    Limone P; Scipioni T; Calvelli P; Scaglione E; Barberis AM; Dentelli P; Isaia GC; Molinatti GM
    J Clin Endocrinol Metab; 1994 Aug; 79(2):571-5. PubMed ID: 8045978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inhibitory effects of interleukin-1a on basal gonadotropin release in the ovariectomized rhesus monkey: reversal by a corticotropin-releasing factor antagonist.
    Feng YJ; Shalts E; Xia LN; Rivier J; Rivier C; Vale W; Ferin M
    Endocrinology; 1991 Apr; 128(4):2077-82. PubMed ID: 1900786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transdermal 17 beta-estradiol treatment and naloxone infusion on gonadotropin response to gonadotropin-releasing hormone in postmenopausal women.
    Cagnacci A; Melis GB; Paoletti AM; Soldani R; Fioretti P
    J Clin Endocrinol Metab; 1990 Feb; 70(2):365-70. PubMed ID: 2105330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
    Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of prolactin and pituitary-adrenal axis components as intervening variables in the adrenalectomy-induced inhibition of gonadotropin response to castration.
    Ringstrom SJ; Schwartz NB
    Endocrinology; 1984 Mar; 114(3):880-7. PubMed ID: 6321145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.
    Baranowska B; Rozbicka G; Jeske W; Abdel-Fattah MH
    J Clin Endocrinol Metab; 1984 Sep; 59(3):412-6. PubMed ID: 6086696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acylated ghrelin inhibits spontaneous luteinizing hormone pulsatility and responsiveness to naloxone but not that to gonadotropin-releasing hormone in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis.
    Lanfranco F; Bonelli L; Baldi M; Me E; Broglio F; Ghigo E
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3633-9. PubMed ID: 18559917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea.
    Quigley ME; Sheehan KL; Casper RF; Yen SS
    J Clin Endocrinol Metab; 1980 May; 50(5):949-54. PubMed ID: 6246138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulsatile luteinizing hormone secretion in patients with Addison's disease. Impact of glucocorticoid substitution.
    Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
    J Clin Endocrinol Metab; 1998 Mar; 83(3):736-43. PubMed ID: 9506718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of naloxone on luteinizing hormone, follicle-stimulating hormone, and prolactin secretion in the different phases of the estrous cycle.
    Piva F; Maggi R; Limonta P; Motta M; Martini L
    Endocrinology; 1985 Aug; 117(2):766-72. PubMed ID: 3926461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid sequential intravenous administration of four hypothalamic releasing hormones as a combined anterior pituitary function test in normal subjects.
    Sheldon WR; DeBold CR; Evans WS; DeCherney GS; Jackson RV; Island DP; Thorner MO; Orth DN
    J Clin Endocrinol Metab; 1985 Apr; 60(4):623-30. PubMed ID: 2982903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.